FDA Changes Abortion Drug Labeling, Dosing

In a move that could sharply undercut efforts to limit abortion by medication, the US Food and Drug Administration on Wednesday announced that it had approved new labeling for the country’s most widely used abortion drug, mifepristone, to better reflect what scientific research shows is the most effective way to use the drug.

It is a change public health advocates and reproductive rights activists have sought for more than a decade, as the drug’s outdated labeling, adopted from a label approved by European regulators in the 1980s, became an effective weapon for anti-abortion forces.